252 related articles for article (PubMed ID: 28689321)
61. The impact of synoptic cytology reporting on fine-needle aspiration cytology of thyroid nodules.
Tsan CJ; Serpell JW; Poh YY
ANZ J Surg; 2007 Nov; 77(11):991-5. PubMed ID: 17931264
[TBL] [Abstract][Full Text] [Related]
62. Risk of malignancy in thyroid nodules with atipia of undetermined significance.
López Vázquez Y; Penín Álvarez M; San Miguel Fraile P; Barragáns Pérez M
Endocrinol Nutr; 2015 Dec; 62(10):507-10. PubMed ID: 26526719
[TBL] [Abstract][Full Text] [Related]
63. Evaluation of cytologically benign solitary thyroid nodules by ultrasonography: a retrospective analysis of 1877 cases.
Kihara M; Hirokawa M; Masuoka H; Yabuta T; Shindo H; Higashiyama T; Fukushima M; Yamada O; Takamura Y; Ito Y; Kobayashi K; Miya A; Miyauchi A
Auris Nasus Larynx; 2013 Jun; 40(3):308-11. PubMed ID: 23103151
[TBL] [Abstract][Full Text] [Related]
64. A histological assessment of the Bethesda system for reporting thyroid cytopathology (2010) abnormal categories: a series of 219 consecutive cases.
Tepeoğlu M; Bilezikçi B; Bayraktar SG
Cytopathology; 2014 Feb; 25(1):39-44. PubMed ID: 23438201
[TBL] [Abstract][Full Text] [Related]
65. Malignancy risk stratification in thyroid nodules with nondiagnostic results at cytologic examination: combination of thyroid imaging reporting and data system and the Bethesda System.
Moon HJ; Kim EK; Yoon JH; Kwak JY
Radiology; 2015 Jan; 274(1):287-95. PubMed ID: 25133852
[TBL] [Abstract][Full Text] [Related]
66. Impact of Afirma gene expression classifier on cytopathology diagnosis and rate of thyroidectomy.
Sacks WL; Bose S; Zumsteg ZS; Wong R; Shiao SL; Braunstein GD; Ho AS
Cancer Cytopathol; 2016 Oct; 124(10):722-728. PubMed ID: 27347838
[TBL] [Abstract][Full Text] [Related]
67. Risk of malignancy for each Bethesda class in pediatric thyroid nodules.
Norlén O; Charlton A; Sarkis LM; Henwood T; Shun A; Gill AJ; Delbridge L
J Pediatr Surg; 2015 Jul; 50(7):1147-9. PubMed ID: 25783310
[TBL] [Abstract][Full Text] [Related]
68. Additional Surgery for Occult Risk Factors After Lobectomy in Solitary Thyroid Nodules is Predicted by Cytopathology Classification and Tumor Size.
Flagg A; Rooper L; Sheth S; Shaear M; Santhanam P; Prescott J; Olson MT; Bishop JA; Mammen JS
Endocr Pract; 2020 Jul; 26(7):754-760. PubMed ID: 33471644
[TBL] [Abstract][Full Text] [Related]
69. Surgeon-performed ultrasound can predict benignity in thyroid nodules.
Goldfarb M; Gondek S; Solorzano C; Lew JI
Surgery; 2011 Sep; 150(3):436-41. PubMed ID: 21878228
[TBL] [Abstract][Full Text] [Related]
70. The surgical approach to nodule Thyr 3-4 after the 2.2014 NCCN and 2015 ATA guidelines.
Del Rio P; Pisani P; Montana Montana C; Cataldo S; Marina M; Ceresini G
Int J Surg; 2017 May; 41 Suppl 1():S21-S25. PubMed ID: 28506409
[TBL] [Abstract][Full Text] [Related]
71. Effectiveness of the thyroid scan in evaluation of the solitary thyroid nodule.
Sabel MS; Staren ED; Gianakakis LM; Dwarakanathan S; Prinz RA
Am Surg; 1997 Jul; 63(7):660-3; discussion 663-4. PubMed ID: 9202544
[TBL] [Abstract][Full Text] [Related]
72. Outcome of long standing solitary thyroid nodules.
Kuma K; Matsuzuka F; Kobayashi A; Hirai K; Morita S; Miyauchi A; Katayama S; Sugawara M
World J Surg; 1992; 16(4):583-7; discussion 587-8. PubMed ID: 1413828
[TBL] [Abstract][Full Text] [Related]
73. The role of fine-needle aspiration cytology in the surgical management of thyroid cancer.
Raj MD; Grodski S; Martin SA; Yeung M; Serpell JW
ANZ J Surg; 2010 Nov; 80(11):827-30. PubMed ID: 20969692
[TBL] [Abstract][Full Text] [Related]
74. Risk factors for malignancy in patients with solitary thyroid nodules and their impact on the management.
Tai JD; Yang JL; Wu SC; Wang BW; Chang CJ
J Cancer Res Ther; 2012; 8(3):379-83. PubMed ID: 23174718
[TBL] [Abstract][Full Text] [Related]
75. Risk of Malignancy in Thyroid Nodules with Non-Diagnostic Fine-Needle Aspiration: A Retrospective Cohort Study.
Espinosa De Ycaza AE; Lowe KM; Dean DS; Castro MR; Fatourechi V; Ryder M; Morris JC; Stan MN
Thyroid; 2016 Nov; 26(11):1598-1604. PubMed ID: 27549368
[TBL] [Abstract][Full Text] [Related]
76. Thyroid cancer in the thyroid nodules evaluated by ultrasonography and fine-needle aspiration cytology.
Lin JD; Chao TC; Huang BY; Chen ST; Chang HY; Hsueh C
Thyroid; 2005 Jul; 15(7):708-17. PubMed ID: 16053388
[TBL] [Abstract][Full Text] [Related]
77. Malignancy risk of oncocytic changes in thyroid nodules: who should we offer surgery to?
Yazici P; Yilmaz B; Bozkurt E; Mihmanli M; Uludag M
Acta Chir Belg; 2016 Feb; 116(1):30-5. PubMed ID: 27385138
[TBL] [Abstract][Full Text] [Related]
78. Molecular testing for cytologically suspicious and malignant (Bethesda V and VI) thyroid nodules to optimize the extent of surgical intervention: a retrospective chart review.
Hier J; Avior G; Pusztaszeri M; Krasner JR; Alyouha N; Forest VI; Hier MP; Mlynarek A; Richardson K; Sadeghi N; Tamilia M; Payne RJ
J Otolaryngol Head Neck Surg; 2021 Apr; 50(1):29. PubMed ID: 33910629
[TBL] [Abstract][Full Text] [Related]
79. The diagnostic accuracy of ultrasound-guided fine-needle aspiration biopsy for thyroid nodules three centimeters or larger in size.
Ucler R; Usluogulları CA; Tam AA; Ozdemir D; Balkan F; Yalcın S; Kıyak G; Ersoy PE; Guler G; Ersoy R; Cakır B
Diagn Cytopathol; 2015 Aug; 43(8):622-8. PubMed ID: 25914194
[TBL] [Abstract][Full Text] [Related]
80. Concordance between thyroid nodule sizes measured by ultrasound and gross pathology examination: effect on patient management.
Deveci MS; Deveci G; LiVolsi VA; Gupta PK; Baloch ZW
Diagn Cytopathol; 2007 Sep; 35(9):579-83. PubMed ID: 17703450
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
